Skip to content
Subscriber Only

Sanofi Said to Consider Adding Future Payments to Medivation Bid

  • French drugmaker said to discuss ‘contingent value rights’
  • Sanofi executives said to push offer in investor meetings
French drugmaker group Sanofi new CEO Olivier Brandicourt.

French drugmaker group Sanofi new CEO Olivier Brandicourt.

Photographer: Eric Piermont/AFP via Getty Images

Sanofi, the French drugmaker, is considering improving its $9.3 billion takeover offer for Medivation Inc. by committing to making future payments if the U.S. biotech company meets certain targets, according to people familiar with the matter.

Sanofi executives met with Medivation investors in recent days to discuss the inclusion of so-called contingent value rights as part of a potential sweetened bid for the company, said the people, who asked not to be identified because talks are private.